Abbott Laboratories vs. Kazia Therapeutics Limited American Depositary Shares
ABT
Abbott Laboratories
$112.47 +0.79%
VS KZIAKazia Therapeutics Limited American Depositary Shares
$13.58 -19.64%
Abbott Laboratories and Kazia Therapeutics Limited American Depositary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | KZIA | |
|---|---|---|
| Market Cap | $194.62 billion | $155.18 million |
| Revenue (TTM) | $46.59 billion | — |
| Net Income (TTM) | $5.42 billion | — |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | KZIA | |
|---|---|---|
| P/E Ratio | 36.40 | — |
| Price / Book | 3.76 | — |
| Price / Sales | 4.18 | — |
ABT and KZIA split the valuation factors evenly.
Profitability
| ABT | KZIA | |
|---|---|---|
| Net Margin | 11.65% | — |
| Return on Equity | 10.48% | — |
ABT and KZIA split the profitability factors evenly.
Dividend
| ABT | KZIA | |
|---|---|---|
| Dividend Yield | 2.24% | — |
| Payout Ratio | 81.55 | — |
ABT and KZIA split the dividend factors evenly.
Risk & Sentiment
| ABT | KZIA | |
|---|---|---|
| Short Interest | 0.57% | 0.04% |
KZIA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, KZIA overview, KZIA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.